BioInvest.com is the web portal of the Medical Technology Stock Letter. In addition to providing convenient access to the Letter, this site includes in-depth research and analysis of a unique portfolio of bio-pharmaceutical companies and our insights regarding relevant trends in the biotechnology industry.
BioInvest.com helps individual and professional investors stay ahead of the curve with timely information about market-moving events and by offering comprehensive analysis of company and industry catalysts. When appropriate, we also guide our readers to other websites such as ClinicalTrials.gov to gain a complete understanding of the medicines and technologies being developed by the companies we follow.
From time to time, independent contributors will provide added value for our subscribers to gain additional viewpoints on relevant topics (e.g., whitepapers) of interest for the current and future biotechnology industry.